Sanofi India Limited (SANOFI) — Financial Results | 2 April 2026

StockFin.ai

Try Free

Sanofi India Limited reported a 69.9% year-on-year revenue increase to ₹87.22 crores for Q3 FY2026, driven by strong performance in its core pharmaceutical segments. The company declared an interim dividend of ₹75 per share and reaffirmed its commitment to sustainable growth through strategic capital allocation. Board appointments and related party transaction approvals underscore governance focus, though near-term growth faces headwinds from regulatory and market volatility.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SANOFI ✨ Ask AI About This

About Sanofi India Limited (SANOFI)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹7,411.02 Cr P/E: 17.9

View full SANOFI stock details →

📡 Get AI alerts when SANOFI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SANOFI — Free

💡 Ask AI about this filing

"How does this financial results affect Sanofi India Limited's outlook?" "What did Sanofi India Limited announce on 2 April 2026?" "Is this positive or negative for SANOFI?"

Ask AI Free →

📊 More SANOFI filings

See all SANOFI filings →

🔥 Also filed on 2 April 2026

PSB Punjab & Sind Bank Insider Trading UBL United Breweries Limited Announcement RITCO Ritco Logistics Limited Financial Results SAIL Steel Authority of India Limited Announcement TRANSWORLD TRANSWORLD SHIPPING LINES LIMITED Announcement 21STCENMGM 21st Century Management Services Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SANOFI files new disclosures

Track SANOFI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SANOFI — Free

Free account · 2 AI queries/day